Dr Daniel Croker
Targeting neuroinflammatory pathways as novel treatments for dementia
Alzheimer's disease & other dementias
complement c5a | dementia | neuroinflammatory disease | microglia | innate immunity
Australia has a rapid increase in its ageing population, and consequently an increase in detrimental age-related dementia and neurodegenerative diseases which are a major healthcare burden. Current treatments for diseases such as Alzheimers, Parkinsons and Huntingtons are inadequate and there is a desperate need for new treatments. I have unique access to molecules that target two novel mechanisms for neurodegenerative diseases. This fellowship will explore their therapeutic potential.